| ||||||||||||||
|
|
|||||||||||||




*Pharmacy Department and
Department of Anesthesia, Intensive Care, and Pain Medicine, Repatriation General Hospital, Daw Park, Australia; and
Royal Danish School of Pharmacy, Copenhagen, Denmark
Address correspondence and reprint requests to Greg Roberts, Pharmacy Department, Repatriation General Hospital, Daws Rd., Daw Park SA 5041, Australia. Address e-mail to greg.roberts{at}rgh.sa.gov.au.
We prospectively examined the incidence of postoperative nausea and vomiting (PONV) in a group of 193 elderly surgical inpatients receiving no postoperative antiemetic prophylaxis. Risk factors for PONV and detailed data on postoperative opioid use were recorded. The overall postoperative vomiting (POV) rate was 23.8%, whereas postoperative nausea (PON) was 51.3%. Opioid use (P = 0.025), and female gender (P = 0.038) were identified as significantly influencing POV in this relatively small population. There was a strong logarithmic dose-response relationship between postoperative opioid dose and POV (r2 = 0.98, P < 0.01), as well as PON (r2 = 0.98, P = 0.01). Use of patient-controlled analgesia or epidural analgesia was a marker for large-dose opioid use (P < 0.001) and was associated with POV in the 24-h postoperative period of 41% and 31% respectively, compared with 11% for other patients (P < 0.001). Future studies defining risk factors for POV should treat postoperative opioid use as a continuous variable, rather than treat it as a dichotomous variable.
This article has been cited by other articles:
![]() |
M. Coburn, O. Kunitz, C. C. Apfel, M. Hein, M. Fries, and R. Rossaint Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia Br. J. Anaesth., June 1, 2008; 100(6): 787 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan, T. A. Meyer, C. C. Apfel, F. Chung, P. J. Davis, A. S. Habib, V. D. Hooper, A. L. Kovac, P. Kranke, P. Myles, et al. Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting Anesth. Analg., December 1, 2007; 105(6): 1615 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Kim, S. B. Nam, M. J. Cho, and Y.-S. Shin Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia Br. J. Anaesth., August 1, 2007; 99(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan Risk factors for postoperative nausea and vomiting. Anesth. Analg., June 1, 2006; 102(6): 1884 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Redmond and P. Glass Opiate-Induced Nausea and Vomiting: What Is the Challenge? Anesth. Analg., November 1, 2005; 101(5): 1341 - 1342. [Full Text] [PDF] |
||||
|